Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PCVX |
---|---|---|
09:32 ET | 1997 | 59.59 |
09:34 ET | 1300 | 59.49 |
09:36 ET | 800 | 59.49 |
09:38 ET | 400 | 59.49 |
09:39 ET | 17920 | 59.745 |
09:41 ET | 400 | 58.99 |
09:43 ET | 24015 | 59.15 |
09:45 ET | 743 | 59.155 |
09:48 ET | 35337 | 59.155 |
09:50 ET | 1325 | 58.61 |
09:52 ET | 16179 | 59.14 |
09:54 ET | 1100 | 59.105 |
09:56 ET | 1100 | 59.07 |
09:57 ET | 400 | 59.04 |
09:59 ET | 600 | 59.005 |
10:01 ET | 800 | 58.73 |
10:03 ET | 1213 | 58.78 |
10:06 ET | 600 | 59.04 |
10:08 ET | 300 | 58.905 |
10:10 ET | 500 | 59.04 |
10:12 ET | 1229 | 59.13 |
10:14 ET | 4931 | 59.04 |
10:15 ET | 200 | 59.03 |
10:17 ET | 700 | 59.15 |
10:19 ET | 2361 | 59.17 |
10:21 ET | 400 | 59.08 |
10:24 ET | 500 | 58.96 |
10:26 ET | 1800 | 58.76 |
10:28 ET | 1145 | 58.92 |
10:30 ET | 2642 | 59.04 |
10:32 ET | 700 | 59.04 |
10:33 ET | 600 | 58.945 |
10:35 ET | 3600 | 59.035 |
10:37 ET | 2315 | 59 |
10:39 ET | 1658 | 59.07 |
10:42 ET | 1700 | 58.96 |
10:44 ET | 1328 | 59.13 |
10:46 ET | 700 | 59.13 |
10:48 ET | 1237 | 59.135 |
10:50 ET | 696 | 59.24 |
10:53 ET | 1399 | 59.35 |
10:55 ET | 1101 | 59.39 |
10:57 ET | 827 | 59.42 |
11:00 ET | 2300 | 59.33 |
11:02 ET | 2200 | 59.425 |
11:04 ET | 500 | 59.455 |
11:06 ET | 2000 | 59.3 |
11:08 ET | 950 | 59.3363 |
11:09 ET | 500 | 59.245 |
11:11 ET | 1706 | 59.415 |
11:13 ET | 602 | 59.435 |
11:15 ET | 1925 | 59.45 |
11:18 ET | 500 | 59.51 |
11:20 ET | 1600 | 59.375 |
11:22 ET | 700 | 59.39 |
11:24 ET | 26683 | 59.48 |
11:26 ET | 1600 | 59.4 |
11:27 ET | 3694 | 59.32 |
11:29 ET | 1492 | 59.06 |
11:31 ET | 1280 | 58.945 |
11:33 ET | 35101 | 58.77 |
11:36 ET | 196751 | 58.675 |
11:40 ET | 500 | 58.68 |
11:42 ET | 3573 | 58.74 |
11:44 ET | 300 | 58.74 |
11:45 ET | 8555 | 58.585 |
11:47 ET | 35221 | 58.435 |
11:49 ET | 5463 | 58.39 |
11:51 ET | 9986 | 58.305 |
11:54 ET | 101678 | 58.34 |
11:56 ET | 26304 | 58.39 |
11:58 ET | 16200 | 58.45 |
12:00 ET | 1700 | 58.41 |
12:02 ET | 3310 | 58.46 |
12:03 ET | 1100 | 58.62 |
12:05 ET | 700 | 59.02 |
12:07 ET | 943 | 59.15 |
12:09 ET | 100 | 59.31 |
12:12 ET | 3255 | 59.43 |
12:14 ET | 24010 | 59.19 |
12:16 ET | 33953 | 59.275 |
12:18 ET | 100 | 59.315 |
12:20 ET | 1100 | 59.16 |
12:21 ET | 1100 | 59.3 |
12:23 ET | 953 | 59.33 |
12:25 ET | 467 | 59.335 |
12:27 ET | 1754 | 59.09 |
12:30 ET | 600 | 59.08 |
12:32 ET | 720 | 59.075 |
12:34 ET | 52635 | 59.4182 |
12:36 ET | 200 | 59.29 |
12:38 ET | 1600 | 59.27 |
12:39 ET | 100 | 59.06 |
12:41 ET | 200 | 59.2 |
12:43 ET | 500 | 59.16 |
12:45 ET | 900 | 59.34 |
12:48 ET | 900 | 59.445 |
12:50 ET | 600 | 59.42 |
12:52 ET | 1100 | 59.375 |
12:54 ET | 690 | 59.5 |
12:56 ET | 611 | 59.515 |
12:57 ET | 100 | 59.51 |
12:59 ET | 400 | 59.54 |
01:01 ET | 400 | 59.52 |
01:03 ET | 1700 | 59.46 |
01:06 ET | 2305 | 59.515 |
01:08 ET | 1240 | 59.465 |
01:10 ET | 700 | 59.42 |
01:12 ET | 500 | 59.47 |
01:14 ET | 400 | 59.37 |
01:15 ET | 100 | 59.33 |
01:17 ET | 100 | 59.43 |
01:19 ET | 900 | 59.34 |
01:21 ET | 600 | 59.27 |
01:24 ET | 1000 | 59.1 |
01:26 ET | 1226 | 59.205 |
01:28 ET | 51114 | 59.28 |
01:30 ET | 10068 | 59.2495 |
01:32 ET | 38878 | 59.09 |
01:33 ET | 700 | 59.13 |
01:35 ET | 1100 | 59.23 |
01:37 ET | 2239 | 59.3 |
01:39 ET | 400 | 59.385 |
01:42 ET | 304 | 59.38 |
01:46 ET | 5290 | 59.535 |
01:48 ET | 9968 | 59.53 |
01:50 ET | 300 | 59.53 |
01:51 ET | 11041 | 59.53 |
01:53 ET | 2400 | 59.8 |
01:55 ET | 600 | 59.86 |
01:57 ET | 1175 | 59.78 |
02:00 ET | 2134 | 59.8 |
02:02 ET | 100 | 59.77 |
02:04 ET | 1300 | 59.51 |
02:06 ET | 1500 | 59.58 |
02:08 ET | 2100 | 59.62 |
02:09 ET | 500 | 59.67 |
02:11 ET | 600 | 59.75 |
02:13 ET | 200 | 59.65 |
02:15 ET | 544 | 59.76 |
02:18 ET | 300 | 59.72 |
02:20 ET | 584 | 59.75 |
02:22 ET | 1100 | 59.855 |
02:24 ET | 400 | 59.77 |
02:26 ET | 435 | 59.735 |
02:27 ET | 800 | 59.805 |
02:29 ET | 1103 | 59.64 |
02:31 ET | 700 | 59.595 |
02:33 ET | 1800 | 59.65 |
02:36 ET | 100 | 59.52 |
02:38 ET | 1576 | 59.615 |
02:40 ET | 13091 | 59.66 |
02:42 ET | 2335 | 59.575 |
02:44 ET | 300 | 59.51 |
02:45 ET | 1677 | 59.5 |
02:47 ET | 1800 | 59.555 |
02:49 ET | 1980 | 59.51 |
02:51 ET | 900 | 59.59 |
02:54 ET | 1000 | 59.53 |
02:56 ET | 2433 | 59.553 |
02:58 ET | 1500 | 59.52 |
03:00 ET | 700 | 59.555 |
03:02 ET | 1518 | 59.61 |
03:03 ET | 700 | 59.68 |
03:05 ET | 1718 | 59.73 |
03:07 ET | 1300 | 59.64 |
03:09 ET | 400 | 59.62 |
03:12 ET | 700 | 59.58 |
03:14 ET | 2500 | 59.6 |
03:16 ET | 568 | 59.52 |
03:18 ET | 500 | 59.57 |
03:20 ET | 918 | 59.62 |
03:21 ET | 1900 | 59.6 |
03:23 ET | 2987 | 59.56 |
03:25 ET | 9815 | 59.57 |
03:27 ET | 1101 | 59.565 |
03:30 ET | 4466 | 59.485 |
03:32 ET | 1200 | 59.475 |
03:34 ET | 4315 | 59.47 |
03:36 ET | 4713 | 59.525 |
03:38 ET | 2977 | 59.54 |
03:39 ET | 1540 | 59.48 |
03:41 ET | 1335 | 59.465 |
03:43 ET | 44630 | 59.465 |
03:45 ET | 36168 | 59.51 |
03:48 ET | 4349 | 59.55 |
03:50 ET | 6196 | 59.7 |
03:52 ET | 14379 | 59.775 |
03:54 ET | 8932 | 59.81 |
03:56 ET | 13379 | 59.87 |
03:57 ET | 25398 | 60.015 |
03:59 ET | 155597 | 60.06 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vaxcyte Inc | 6.6B | -14.7x | --- |
Cytokinetics Inc | 7.0B | -11.9x | --- |
Viking Therapeutics Inc | 7.2B | -74.0x | --- |
Revolution Medicines Inc | 5.9B | -9.4x | --- |
Cerevel Therapeutics Holdings Inc | 7.6B | -15.8x | --- |
BridgeBio Pharma Inc | 4.6B | -6.2x | --- |
Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). VAX-31, the Company’s next generation 31-valent PCV is developed for the prevention of IPD in adults. Its pipeline also includes VAX-A1, VAX-PG, and VAX-GI. VAX-A1, a novel conjugate vaccine candidate designed to prevent disease caused by Group A Streptococcus (Group A Strep). VAX-PG, a novel protein vaccine candidate targeting pathogen responsible for periodontitis, a chronic oral inflammatory disease. VAX-GI, a novel preclinical vaccine candidate being developed as a preventative treatment for dysentery and shigellosis. Its technology platform includes advanced chemistry and the XpressCF cell-free protein synthesis platform.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.6B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 108.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.94 |
EPS | $-4.07 |
Book Value | $13.01 |
P/E Ratio | -14.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.